BioPorto A/S (THOXF)
| Previous close | 0.3100 |
| Open | 0.3100 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 0.3100 - 0.3100 |
| 52-week range | 0.2120 - 0.4345 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 117.694M |
| Beta (5Y monthly) | 1.19 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
BioPorto A/S Appoints President and CEO of BioPorto Inc.
May 7, 2024News release BioPorto A/S Appoints President and CEO of BioPorto Inc. COPENHAGEN, DENMARK and BOSTON, MA, USA, May 7, 2024, (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto or Company) (CPH:BIOPOR), an in vitro diagnostics company focused on empowering the early detection of Acute Kidney Injury (AKI), announced today the appointment of Jeffrey N. Haas as new President and Chief Executive Officer of BioPorto Inc. (US), the fully owned subsidiary of BioPorto, and member of the Group’s Executi
- GlobeNewswire
BioPorto A/S to Host First Quarter 2024 Earnings Webcast and Investor Meeting
May 2, 2024News release BioPorto A/S to Host First Quarter 2024 Earnings Webcast and Investor Meeting COPENHAGEN, DENMARK and BOSTON, MA, USA, May 2, 2024 (GLOBE NEWSWIRE) – BioPorto A/S (BioPorto or the Company) (CPH:BIOPOR), an in vitro diagnostics company focused on empowering the early detection of Acute Kidney Injury (AKI), announced today that, in connection with the release of its Interim Report for the first quarter ending March 31, 2024, the Company’s management team will host an online
- GlobeNewswire
Resolutions of Annual Geneal Meeting
April 30, 2024Announcement no. 10 Resolutions of Annual Geneal Meeting COPENHAGEN, DENMARK and BOSTON, MA, USA, April 30, 2024, (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto or Company) (CPH:BIOPOR), an in vitro diagnostics company focused on empowering the early detection of Acute Kidney Injury (AKI), today held its Annual General Meeting with the following results: ITEM 1 - The Board's report on the Company’s activities during the past year was noted by the Annual General Meeting. ITEM 2 – The an
